Response and Toxicity of Chemotherapy in 78Cases of Malignant Ovarian Tumors.
- Author:
Jae yeon WON
;
Il Soo PARK
;
Soon Gu HWANG
- Publication Type:Original Article
- Keywords:
malignant ovarian tumors;
combination chemotherapy
- MeSH:
Anemia;
Drug Therapy*;
Drug Therapy, Combination;
Gynecology;
Humans;
Leukopenia;
Melphalan;
Obstetrics;
Thrombocytopenia
- From:Korean Journal of Gynecologic Oncology and Colposcopy
1996;7(2):127-134
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
For evaluation of the response and toxicity of the combination chemotherapy, forty six patients with malignant ovarian tumors who had prior surgery were treated with combination chemotherapy from January 1985 to March 1991 at the Department of Obstetrics and Gynecology, Kyung-pook National University Hospital. The results were as follows : 1. The responses were in complete 20 cases(43.5%), in partial 9 cases(19,6%), in stable 6 cases(13.0%), in progressive 11 cases(23.9%) among 46 patients. 2. By the response rates of various combination chemotherapy regimens, the response rate of CAP was 64%(16/25), CP 57.1%(8/14), VAC 100%(3/3), VBP 50%(1/2), FAM 0%(0/1), and Melphalan 100%(1/1) respectively. 3. As the chemotoxicities of combination chemotherapy, leukopenia 20 cases(46.5%), thrombocytopenia 2 cases(4.7%), anemia 20 cases(46.5%), nephrotoxity 6 cases(14.6%), hepatotoxicity 7 cases(18.4%) were observed.
